Studie M15-531

M15-531

This is a Phase 2, open-label, 3-arm randomized, multicenter study designed to determine the safety, pharmacokinetics, and efficacy of venetoclax when administered with azacitidine, compared to azacitidine alone, in subjects with treatment-naïve higher-risk MDS Labornummer: Z324

NCT02942290

3. Med 3. Med Ismaninger Str. 22 81675 München Germany

I

Rekrutierung beendet

Positiv

2017-01-10

Unbekannt / Unbekannt

Chemo